Faculty profile

John-Michael Gamble

ResearcherMemorial University of Newfoundland

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Memorial University of Newfoundland directory, so their courses may be missing. Find their university profile.

John-Michael Gamble

Researcher

Health Sciences

Memorial University of Newfoundland

St. John's, Newfoundland and Labrador, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2020.
Principal investigator on 2 research grants (2 CIHR), most recently in 2012.
Supervised 1 trainee who won CIHR awards, most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Diabetes Drug Safety And Effectiveness Health Outcomes Pharmacoepidemiology Cohort Study Comparative Effectiveness Research Database Analysis Population Health

Latest papers

Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment.
Canadian journal of diabetes · 2020 · senior author
Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis.
BMJ open · 2019 · senior author
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes.
Scientific reports · 2018 · first author

All 20 publications

Latest funding

Effects of Canadian Smoking Policies on Children's Use of E-Cigarettes and Exposure to Second-Hand Smoke in Cars
CIHR · 2018 · Co-investigator
$49,200
Integrating Patient Preferences into Quantitative Benefit-Risk Assessment of the Sodium-Glucose Transport Protein 2 Inhibitors
CIHR · 2016 · Supervisor
$165,000
Connecting Policy and Practice Through the Health Sectors and Across Health Disciplines: A SPOR Network in Primary and Integrated Health Care Innovations
CIHR · 2014 · Co-investigator
$75,000

All 5 grants and awards

20 publications.

Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment.

Donnan JR, Johnston K, Chibrikov E, Marra CA, Aubrey-Bassler K, Najafzadeh M, Nguyen H, Gamble JM

Canadian journal of diabetes2020Senior author

DOI: 10.1016/j.jcjd.2019.04.014 PMID: 31311729

Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis.

Donnan JR, Grandy CA, Chibrikov E, Marra CA, Aubrey-Bassler K, Johnston K, Swab M, Hache J, Curnew D, Nguyen H, Gamble JM

BMJ open2019Senior author

DOI: 10.1136/bmjopen-2018-022577 PMID: 30813108

Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes.

Gamble JM, Donnan JR, Chibrikov E, Twells LK, Midodzi WK, Majumdar SR

Scientific reports2018First author

DOI: 10.1038/s41598-018-33483-y PMID: 30310100

Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink.

Gamble JM, Chibrikov E, Midodzi WK, Twells LK, Majumdar SR

BMJ open2018First author

DOI: 10.1136/bmjopen-2018-023830 PMID: 30297350

A systematic assessment of the availability and clinical drug information coverage of machine-readable clinical drug data sources for building knowledge translation products.

Grandy CA, Donnan JR, Peddle JT, Romme K, Kim S, Gamble JM

Journal of the American Medical Informatics Association : JAMIA2018Senior author

DOI: 10.1093/jamia/ocy074 PMID: 29982512

Diabetes and the occurrence of infection in primary care: a matched cohort study.

Abu-Ashour W, Twells LK, Valcour JE, Gamble JM

BMC infectious diseases2018Senior author

DOI: 10.1186/s12879-018-2975-2 PMID: 29402218

The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study.

Gamble JM, Donnan JR, Chibrikov E, Twells LK, Midodzi WK, Majumdar SR

Diabetes research and clinical practice2018First author

DOI: 10.1016/j.diabres.2017.12.008 PMID: 29258886

The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin.

Anand K, Sketris I, Zhang Y, Levy A, Gamble JM

Drugs - real world outcomes2017Senior author

DOI: 10.1007/s40801-017-0116-7 PMID: 28956294

The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies.

Abu-Ashour W, Twells L, Valcour J, Randell A, Donnan J, Howse P, Gamble JM

BMJ open diabetes research & care2017Senior author

DOI: 10.1136/bmjdrc-2016-000336 PMID: 28761647

Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study.

Gamble JM, Chibrikov E, Twells LK, Midodzi WK, Young SW, MacDonald D, Majumdar SR

The lancet. Diabetes & endocrinology2017First author

DOI: 10.1016/s2213-8587(16)30316-3 PMID: 27865756

Effects of Canadian Smoking Policies on Children's Use of E-Cigarettes and Exposure to Second-Hand Smoke in Cars

Co-investigatorCIHR2018Operating Grant: ECI grants in Maternal, Reproductive, Child & Youth Health

Principal investigators: Nguyen, Van Hai

Keywords: Public Health Policy; Quasi-Experimental; Second Hand Smoke (Shs) Exposure; Smoking; Survey Data

$49,200

Integrating Patient Preferences into Quantitative Benefit-Risk Assessment of the Sodium-Glucose Transport Protein 2 Inhibitors

SupervisorCIHR2016Fellowship - Priority Announcement: Drug Safety and Effectiveness

Principal investigators: Donnan, Jennifer R

Keywords: Choice Modelling; Discrete Choice Experiment; Drug Safety; Network Meta-Analysis; Patient Preferences; Pharmacoepidemiology; Policy Decision Making; Quantitative Risk Benefit Analysis; Sodium-Glucose Transporter 2 Inhibitor; Type 2 Diabetes

$165,000

Connecting Policy and Practice Through the Health Sectors and Across Health Disciplines: A SPOR Network in Primary and Integrated Health Care Innovations

Co-investigatorCIHR2014SPOR Network in Primary and Integrated Hlth Care Innovations - Nfld & Labrador

Principal investigators: Godwin, Marshall S; Cooper, Bruce; Chan, Kevin J

Keywords: Connecting Policy And Practice; Health System Trasnformation; Integrated Health Care Research; Patient Engagement; Primary Care Reform; Spor

$75,000

Comparative Safety and Effectiveness of the Incretins

Nominated PICIHR2012Operating Grant

Principal investigators: Gamble, John-Michael; Majumdar, Sumit R

Keywords: Cohort Study; Comparative Effectiveness Research; Database Analysis; Diabetes; Drug Safety And Effectiveness; Health Outcomes; Pharmacoepidemiology; Population Health

$150,524

Comparative Safety and Effectiveness of Antidiabetic Medications

Nominated PICIHR2012New Investigator Salary Award - PA: Drug Safety and Effectiveness

Principal investigators: Gamble, John-Michael

Keywords: Diabetes; Drug Safety And Effectiveness; Health Outcomes; Pharmacoepidemiology

$300,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

John-Michael Gamble

Research

Latest papers

Latest funding

Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment.

Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis.

Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes.

Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink.

A systematic assessment of the availability and clinical drug information coverage of machine-readable clinical drug data sources for building knowledge translation products.

Diabetes and the occurrence of infection in primary care: a matched cohort study.

The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study.

The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin.

The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies.

Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study.

Effects of Canadian Smoking Policies on Children's Use of E-Cigarettes and Exposure to Second-Hand Smoke in Cars

Integrating Patient Preferences into Quantitative Benefit-Risk Assessment of the Sodium-Glucose Transport Protein 2 Inhibitors

Connecting Policy and Practice Through the Health Sectors and Across Health Disciplines: A SPOR Network in Primary and Integrated Health Care Innovations

Comparative Safety and Effectiveness of the Incretins

Comparative Safety and Effectiveness of Antidiabetic Medications

Frequent collaborators

John-Michael Gamble

Kris Aubrey-Bassler

Adrian Levy

Jennifer Donnan

Laurie Twells